ARCHIVES

Going private may allow US Oncology to restructure, respond to Medicare cuts; equity investment firm offers to purchase shares.

This article is from The Cancer Letter archive.

Vol. 30 No. 17 | April 23, 2004

Download PDF Visit The Full Archive

Related Articles

Chabner Criticizes FDA Crackdown On Off-Label Info

June 28, 1991

NCI, FDA Courting Drug Sponsors To Add Clinical Trials To PDQ Database

October 11, 1996

ASCO Annual Meeting: PARP Inhibitors Show Promise Against Breast Cancer In Small Phase II Studies

June 5, 2009

Roswell Park, Karmanos Read The Cancer Letter Interactive.

December 1, 2000

Freshman Congressman Launches Drive for “Adequate” Cancer Research Funding

August 5, 1983

Why Shouldn’t Scientific Issues Be Discussed In Open Meetings? Editorial

November 10, 1989